皮膚じんましん治療市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、治療法別、投与経路別、流通チャネル別、地域別、競合、2019～2029年

皮膚じんましん治療の世界市場は2023年に27億5,000万米ドルと評価され、2029年のCAGRは8.05%で、予測期間中に目覚ましい成長を予測しています。

皮膚じんましん治療市場は、その拡大と多様化に寄与する様々な要因によって、著しい成長と進化を遂げています。じんましんは、蕁麻疹としても知られ、皮膚上の赤く痒い湿疹や隆起したぶつぶつを特徴とする一般的なアレルギー性皮膚疾患であり、多くの場合、特定の食物、薬剤、虫刺され、環境要因に対するアレルギー反応によって引き起こされます。じんましん治療市場は、アレルギー疾患の世界の発生率の上昇により勢いを増しており、毎年数100万人がじんましんの影響を受けています。

皮膚じんましん治療市場の促進要因の一つは、皮膚じんましん疾患の有病率の増加です。近年、アレルギーはより一般的なものとなっており、あらゆる年齢層や背景の人々が罹患しています。皮膚のじんましんは、最も目立ち不快なアレルギー反応の一つであるため、患者は即座に緩和を求めており、効果的な治療オプションへの需要が高まっています。市場成長を後押しするもう一つの重要な要因は、迅速かつ効率的な緩和薬に対する需要の高まりです。急性のじんましんエピソードに悩まされる患者は、しばしば強いかゆみ、腫れ、不快感を経験するため、迅速かつ信頼性の高い治療が必要となります。そのため、製薬会社はじんましん患者に迅速な救済を提供するため、抗ヒスタミン薬、コルチコステロイド、エピネフリン注射薬など、即効性と持続性のある薬剤を処方する研究開発に投資しています。

医療研究と技術の進歩も、皮膚じんましん治療市場の形成に極めて重要な役割を果たしています。現在進行中の研究では、免疫系の異常や遺伝的素因など、じんましんの根本的な原因を解明することに重点が置かれています。このような深い知識が、標的療法、個別化された治療計画、特定のじんましん誘因や患者プロファイルに合わせた新規薬剤の開発を可能にしています。その結果、この市場は革新的でより効果的な治療法の導入を示し、患者にとってより良い転帰と生活の質の向上を保証しています。さらに、皮膚じんましんとその誘因に対する認識が、医療専門家と一般住民の間で高まっています。医療従事者は、じんましんを引き起こす多様な要因を認識するようになり、正確な診断と適切な治療を提供できるようになっています。さらに、一般市民向けの啓発キャンペーンや教育的取り組み、オンライン・リソースにより、じんましんの症状を特定し、適時に医師の診断を受け、処方された治療を遵守することができるようになり、じんましん治療ソリューションの需要が高まっています。

従来の医薬品による治療に加えて、じんましん治療に対するホリスティックで自然なアプローチへの関心や投資も高まっています。ハーブ療法、食生活の改善、ストレス管理法、鍼治療のような代替療法は、じんましんの症状を管理するための自然で非侵襲的なソリューションを求める人々の間で人気を集めています。この動向は皮膚じんましん治療市場を多様化し、医療に関する患者のさまざまな嗜好や信念に対応する幅広い選択肢を提供しています。結論として、皮膚じんましん治療市場は、医療の進歩、患者の意識、進化する治療法の相互作用によって形成されるダイナミックな状況を特徴としています。皮膚じんましん疾患の有病率の増加に伴い、迅速な緩和と個別化された治療に対する需要が高まっているため、市場は継続的な成長と革新が見込まれています。じんましんの引き金やメカニズムに関する新たな知見の発見が調査によって進むにつれて、先進的な治療法の採用が市場に導入され、この一般的なアレルギー症状に罹患している患者の症状管理や生活の質の向上が確実になると期待されています。

主要市場の促進要因

じんましんに対する意識の高まり

革新的な治療オプション

主要市場課題

多様な誘因

慢性性

限られた有効性

個人差

主要市場動向

個別化医療

免疫療法の進歩

自然療法とホリスティック・アプローチ

遺伝的誘因の調査

セグメント別洞察

治療別洞察

投与経路別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 皮膚じんましん治療の世界市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別（慢性じんましん、急性じんましん）
  • 治療別（抗炎症薬、かゆみ止め、抗ヒスタミン薬、その他）
  • 投与経路別（経口剤、局所剤、非経口剤）
  • 流通チャネル別（病院薬局、オンライン薬局、小売薬局）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • タイプ別
  • 治療別
  • 投与経路別
  • 販売チャネル別
  • 地域別

第5章 アジア太平洋の皮膚じんましん治療市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 治療別
  • 投与経路別
  • 流通チャネル別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の皮膚じんましん治療市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 治療別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の皮膚じんましん治療市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 治療別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の皮膚じんましん治療市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 治療別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの皮膚じんましん治療市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 治療別
  • 投与経路別
  • 流通チャネル別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と新興国市場開拓

• 製品発表
• 合併・買収

第12章 皮膚じんましん治療の世界市場のSWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Otsuka Holdings Co., Ltd
• Taiho Pharmaceutical Co., Ltd.
• Amneal Pharmaceuticals LLC
• Galderma SA
• F. Hoffmann-La Roche AG
• Novartis AG
• Dr. Reddy's Laboratories, Ltd.
• Glenmark Pharmaceuticals Ltd.
• Sanofi SA

第15章 戦略的提言

第16章 当社について免責事項

Global Skin Hives Treatment Market was valued at USD 2.75 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.05% through 2029. The Skin Hives Treatment Market is witnessing significant growth and evolution, driven by various factors that collectively contribute to its expansion and diversification. Skin hives, also known as urticaria, is a common allergic skin condition characterized by red, itchy welts or raised bumps on the skin, often triggered by allergic reactions to certain foods, medications, insect bites, or environmental factors. The market for skin hives treatment has gained momentum due to the rising incidence of allergic disorders globally, with millions of people affected by hives each year.

One of the primary drivers fueling the Skin Hives Treatment Market is the increasing prevalence of skin hives disorders. Allergies have become more common in recent years, affecting individuals of all ages and backgrounds. Skin hives, being one of the most visible and discomforting allergic reactions, prompt patients to seek immediate relief, driving the demand for effective treatment options. Another key factor propelling the market growth is the growing demand for quick and efficient relief medications. Patients suffering from acute hives episodes often experience intense itching, swelling, and discomfort, necessitating immediate and reliable remedies. Consequently, pharmaceutical companies are investing in research and development to formulate fast-acting and long-lasting medications, including antihistamines, corticosteroids, and epinephrine injectors, to provide rapid relief to patients experiencing hives.

Advancements in medical research and technology also play a pivotal role in shaping the Skin Hives Treatment Market. Ongoing research efforts focus on understanding the underlying causes of hives, including immune system abnormalities and genetic predispositions. This in-depth knowledge enables the development of targeted therapies, personalized treatment plans, and novel medications tailored to specific hives triggers and patient profiles. As a result, the market witnesses the introduction of innovative and more effective treatment options, ensuring better outcomes and improved quality of life for patients. Furthermore, there is a growing awareness about skin hives and its triggers among both healthcare professionals and the general population. Medical professionals are increasingly recognizing the diverse range of factors that can lead to hives, enabling them to provide accurate diagnoses and appropriate treatments. Additionally, public awareness campaigns, educational initiatives, and online resources have empowered individuals to identify hives symptoms, seek timely medical advice, and adhere to prescribed treatments, thereby driving the demand for hives treatment solutions.

In addition to conventional pharmaceutical interventions, there is a rise in interest and investment in holistic and natural approaches to skin hives treatment. Herbal remedies, dietary modifications, stress management techniques, and alternative therapies like acupuncture are gaining popularity among individuals seeking natural and non-invasive solutions for managing hives symptoms. This trend diversifies the Skin Hives Treatment Market, offering a wide array of options catering to patients' varying preferences and beliefs regarding healthcare. In conclusion, the Skin Hives Treatment Market is characterized by a dynamic landscape shaped by the interplay of medical advancements, patient awareness, and evolving treatment modalities. With the increasing prevalence of skin hives disorders, coupled with the demand for quick relief and personalized treatments, the market is poised for continuous growth and innovation. As research continues to uncover new insights into hives triggers and mechanisms, the market is expected to witness the introduction of advanced therapies, ensuring better symptom management and improved quality of life for individuals affected by this common allergic condition.

Key Market Drivers

Rising awareness about skin hives

The rising awareness about skin hives is a significant driving force behind the Skin Hives Treatment Market. Increased public knowledge about hives symptoms, triggers, and available treatment options has led to early diagnosis and proactive healthcare-seeking behavior. This heightened awareness not only empowers individuals to recognize hives but also encourages them to seek timely medical intervention. Healthcare professionals are better equipped to provide accurate diagnoses and recommend suitable treatments, fostering a more informed patient population. Consequently, the growing awareness has led to a higher demand for hives treatments, driving market growth as pharmaceutical companies develop innovative solutions to meet the needs of an increasingly knowledgeable and proactive patient base.

Innovative treatment options

Innovative treatment options are fueling the growth of the Skin Hives Treatment Market by revolutionizing the management of hives. Pharmaceutical advancements, including novel antihistamines, immune modulators, and targeted therapies, are providing more efficient and tailored solutions. Personalized medicine, backed by genetic research, enables specific treatments addressing individual triggers and symptoms, enhancing efficacy. Additionally, research into holistic approaches, such as herbal remedies and lifestyle modifications, is diversifying the market, catering to diverse patient preferences. These innovations not only improve symptom relief but also minimize side effects, elevating the overall quality of care. As patients and healthcare professionals increasingly embrace these progressive treatments, the market continues to expand, meeting the evolving needs of hives sufferers worldwide.

Key Market Challenges

Diverse Triggers

The diverse range of triggers for skin hives poses a significant challenge for the Skin Hives Treatment Market. Hives can be caused by numerous factors, including allergies, stress, infections, or medications, making it challenging to identify the specific cause in individual patients. This complexity hampers the development of universal treatment approaches, as therapies need to be tailored to address different triggers effectively. Healthcare professionals face the daunting task of conducting extensive diagnostic assessments to pinpoint the underlying cause accurately. Moreover, the variability in triggers necessitates a multifaceted treatment approach, increasing the complexity of designing comprehensive and targeted treatments, thereby posing a challenge for pharmaceutical companies and researchers striving to develop effective solutions for hives sufferers.

Chronic Nature

The chronic nature of skin hives presents a significant challenge for the Skin Hives Treatment Market. Hives often recur intermittently over an extended period, requiring continuous management and treatment. This chronicity places a substantial burden on patients, impacting their quality of life and necessitating long-term medical intervention. Moreover, the need for sustained treatment complicates healthcare providers' efforts to design effective and patient-friendly regimens. Pharmaceutical companies face the challenge of developing therapies that provide enduring relief without adverse side effects, making research and innovation crucial. The chronic nature of hives emphasizes the market's necessity for durable and efficient treatment options, demanding ongoing efforts to address the evolving needs of patients facing this persistent condition.

Limited Efficacy

The limited efficacy of existing treatments poses a significant challenge for the Skin Hives Treatment Market. While various medications are available, they do not guarantee complete relief for all patients. Some individuals may experience only partial symptom alleviation or no improvement at all, leading to frustration and dissatisfaction. This inconsistency in treatment outcomes highlights the need for more effective therapies. Pharmaceutical companies and researchers face the daunting task of developing innovative treatments that offer comprehensive relief, addressing the underlying causes of hives. Overcoming this challenge requires continued investment in research and development to create advanced, targeted therapies capable of providing consistent and substantial relief for individuals afflicted with skin hives.

Individual Variability

Individual variability presents a significant challenge for the Skin Hives Treatment Market. Patients with skin hives often respond differently to various treatments due to their unique genetic makeup, underlying health conditions, and specific triggers. This diversity in individual responses complicates the development of standardized treatment protocols. Tailoring therapies to suit each patient's specific needs is essential, demanding personalized approaches that can address the variability in symptoms and triggers. Healthcare providers face the challenge of determining the most effective treatment for each patient, emphasizing the necessity for precision medicine in hives management. Overcoming this challenge requires innovative research, advanced diagnostic tools, and the development of customizable therapies to cater to the diverse responses among hives sufferers.

Key Market Trends

Personalized Medicine

Personalized medicine stands out as a key trend in the Skin Hives Treatment Market, revolutionizing how hives are managed. By tailoring treatments based on patients' genetic makeup, lifestyle, and triggers, personalized medicine ensures more precise and effective interventions. Advanced diagnostic techniques enable healthcare providers to identify specific markers and triggers unique to each patient, allowing for targeted therapies. This approach minimizes trial-and-error in treatment, enhancing efficacy while reducing adverse effects. Pharmaceutical companies and researchers are increasingly investing in this approach, developing therapies that cater to individual variations. Personalized medicine not only improves patient outcomes but also represents a paradigm shift, offering a more patient-centric and efficient approach to addressing the complexities of skin hives.

Immunotherapy Advancements

Immunotherapy advancements are a prominent trend in the Skin Hives Treatment Market, offering innovative solutions for patients. By harnessing the body's immune system to target hives triggers, immunotherapy presents a promising avenue for more effective and lasting relief. Ongoing research focuses on immune modulators, allergen-specific immunotherapy, and biologics, aiming to enhance the body's response to allergens and reduce hives symptoms. These developments signify a shift toward treatments addressing the root cause of hives, rather than just managing symptoms. As clinical trials yield positive results, immunotherapy options are expanding, providing new hope for patients and reshaping the landscape of hives treatment with cutting-edge, immune-focused therapies.

Natural and Holistic Approaches

Natural and holistic approaches are emerging as a significant trend in the Skin Hives Treatment Market. Increasingly, patients are seeking alternative therapies, such as herbal remedies, dietary modifications, stress management techniques, and acupuncture, to manage hives symptoms. These approaches offer non-invasive, side-effect-free options, aligning with the growing preference for natural healthcare solutions. Additionally, research into the impact of lifestyle factors, such as diet and stress, on hives occurrence, is gaining traction. Pharmaceutical companies and healthcare providers are recognizing the importance of integrating these holistic approaches into conventional treatments, offering a comprehensive and patient-centered approach to hives management. This trend reflects the market's response to the demand for more diverse and holistic hives treatment options, catering to patients' individual preferences and well-being.

Research into Genetic Triggers

Research into genetic triggers has emerged as a pivotal trend in the Skin Hives Treatment Market, revolutionizing hives management. Scientists are delving deep into the genetic factors underlying hives, aiming to identify specific genetic markers and pathways responsible for triggering allergic reactions. This in-depth understanding enables the development of targeted therapies tailored to individual patients, addressing the root cause of hives at a molecular level. Precision medicine, guided by genetic insights, is reshaping treatment protocols, ensuring more effective and personalized interventions. Pharmaceutical companies are investing significantly in genetic research, leading to the creation of innovative therapies that offer precise, genetics-based solutions. This trend signifies a paradigm shift towards advanced, genetics-driven hives treatments, promising enhanced outcomes and improved quality of life for patients.

Segmental Insights

Treatment Insights

Basedon the Treatment, Antihistamines have long been the dominant force in the Skin Hives Treatment Market. These medications effectively block histamine, the chemical responsible for hives symptoms, providing relief from itching, swelling, and discomfort. Available in various forms (prescription and over the counter), antihistamines are widely accessible and commonly prescribed by healthcare providers. While newer therapies and holistic approaches are gaining ground, antihistamines remain the go-to option for managing acute hives episodes. Their proven efficacy, ease of use, and familiarity among both patients and physicians have sustained their dominance. However, the market is evolving with ongoing research, emphasizing the need for a diversified approach that integrates antihistamines with innovative treatments to offer comprehensive solutions for hives sufferers.

Route of Administration Insights

Oral medications have established dominance in the Skin Hives Treatment Market due to their convenience, effectiveness, and ease of administration. Oral antihistamines, corticosteroids, and other systemic medications offer a systemic approach to hives management, providing relief from itching, swelling, and discomfort throughout the body. Their oral form ensures patient compliance, making them a preferred choice for both acute and chronic hives. Moreover, oral medications are easily accessible, available in various formulations, and can be prescribed at different dosage strengths, allowing for personalized treatment plans. This convenience factor, coupled with their proven efficacy, has solidified oral medications' dominance, making them the primary choice for healthcare providers and patients alike in the treatment of skin hives.

Regional Insights

North America stands as the dominant force in the Skin Hives Treatment Market due to several factors. The region boasts advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending, fostering the development of innovative treatments. Additionally, a well-established pharmaceutical industry and a large patient population with allergic conditions contribute to market growth. Moreover, widespread awareness about skin hives, easy accessibility to healthcare services, and favorable reimbursement policies enhance the market's prominence. Collaborations between pharmaceutical companies, research institutions, and healthcare providers further drive advancements. These factors combined establish North America as a leading hub for skin hives treatment, shaping the market's trends and developments.

Key Market Players

Otsuka Holdings Co., Ltd

Taiho Pharmaceutical Co., Ltd

Amneal Pharmaceuticals LLC

Galderma SA

F. Hoffmann-La Roche AG

Novartis AG

Dr. Reddy's Laboratories Ltd.

Glenmark Pharmaceuticals Ltd.

Sanofi SA

Report Scope:

In this report, the Global Skin Hives Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Hives Treatment Market,By Type:

• Chronic Hives
• Acute Hives

Skin Hives Treatment Market,By Treatment:

• Anti-Inflammatory Drugs
• Anti-Itch Drugs
• Antihistamines
• Others

Skin Hives Treatment Market,By Route of Administration:

• Oral
• Topical
• Parenteral

Skin Hives Treatment Market,By Distribution Channel:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Skin Hives Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Skin Hives Treatment Market.

Available Customizations:

Global Skin Hives Treatment market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Skin Hives Treatment Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value
• 4.2.Market Share Forecast
  • 4.2.1.By Type (Chronic Hives, Acute Hives)
  • 4.2.2.By Treatment (Anti-Inflammatory Drugs, Anti-Itch Drugs, Antihistamines, Others)
  • 4.2.3.By Route of Administration (Oral, Topical, Parenteral)
  • 4.2.4.By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies)
  • 4.2.5.By Region
  • 4.2.6.By Company (2023)
• 4.3.Market Map
  • 4.3.1.By Type
  • 4.3.2.By Treatment
  • 4.3.3.By Route of Administration
  • 4.3.4.By Distribution Channel
  • 4.3.5.By Region

5.Asia Pacific Skin Hives Treatment Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Type
  • 5.2.2.By Treatment
  • 5.2.3.By Route of Administration
  • 5.2.4.By Distribution Channel
  • 5.2.5.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Skin Hives Treatment Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Type
      • 5.3.1.2.2.By Treatment
      • 5.3.1.2.3.By Route of Administration
      • 5.3.1.2.4.By Distribution Channel
  • 5.3.2.India Skin Hives Treatment Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Type
      • 5.3.2.2.2.By Treatment
      • 5.3.2.2.3.By Route of Administration
      • 5.3.2.2.4.By Distribution Channel
  • 5.3.3.Australia Skin Hives Treatment Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Type
      • 5.3.3.2.2.By Treatment
      • 5.3.3.2.3.By Route of Administration
      • 5.3.3.2.4.By Distribution Channel
  • 5.3.4.Japan Skin Hives Treatment Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Type
      • 5.3.4.2.2.By Treatment
      • 5.3.4.2.3.By Route of Administration
      • 5.3.4.2.4.By Distribution Channel
  • 5.3.5.South Korea Skin Hives Treatment Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Type
      • 5.3.5.2.2.By Treatment
      • 5.3.5.2.3.By Route of Administration
      • 5.3.5.2.4.By Distribution Channel

6.Europe Skin Hives Treatment Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Type
  • 6.2.2.By Treatment
  • 6.2.3.By Route of Administration
  • 6.2.4.By Distribution Channel
  • 6.2.5.By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Skin Hives Treatment Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Type
      • 6.3.1.2.2.By Treatment
      • 6.3.1.2.3.By Route of Administration
      • 6.3.1.2.4.By Distribution Channel
  • 6.3.2.Germany Skin Hives Treatment Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Type
      • 6.3.2.2.2.By Treatment
      • 6.3.2.2.3.By Route of Administration
      • 6.3.2.2.4.By Distribution Channel
  • 6.3.3.Spain Skin Hives Treatment Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Type
      • 6.3.3.2.2.By Treatment
      • 6.3.3.2.3.By Route of Administration
      • 6.3.3.2.4.By Distribution Channel
  • 6.3.4.Italy Skin Hives Treatment Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Type
      • 6.3.4.2.2.By Treatment
      • 6.3.4.2.3.By Route of Administration
      • 6.3.4.2.4.By Distribution Channel
  • 6.3.5.United Kingdom Skin Hives Treatment Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Type
      • 6.3.5.2.2.By Treatment
      • 6.3.5.2.3.By Route of Administration
      • 6.3.5.2.4.By Distribution Channel

7.North America Skin Hives Treatment Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Type
  • 7.2.2.By Treatment
  • 7.2.3.By Route of Administration
  • 7.2.4.By Distribution Channel
  • 7.2.5.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Skin Hives Treatment Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Type
      • 7.3.1.2.2.By Treatment
      • 7.3.1.2.3.By Route of Administration
      • 7.3.1.2.4.By Distribution Channel
  • 7.3.2.Mexico Skin Hives Treatment Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Type
      • 7.3.2.2.2.By Treatment
      • 7.3.2.2.3.By Route of Administration
      • 7.3.2.2.4.By Distribution Channel
  • 7.3.3.Canada Skin Hives Treatment Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Type
      • 7.3.3.2.2.By Treatment
      • 7.3.3.2.3.By Route of Administration
      • 7.3.3.2.4.By Distribution Channel

8.South America Skin Hives Treatment Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Type
  • 8.2.2.By Treatment
  • 8.2.3.By Route of Administration
  • 8.2.4.By Distribution Channel
  • 8.2.5.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Skin Hives Treatment Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Type
      • 8.3.1.2.2.By Treatment
      • 8.3.1.2.3.By Route of Administration
      • 8.3.1.2.4.By Distribution Channel
  • 8.3.2.Argentina Skin Hives Treatment Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Type
      • 8.3.2.2.2.By Treatment
      • 8.3.2.2.3.By Route of Administration
      • 8.3.2.2.4.By Distribution Channel
  • 8.3.3.Colombia Skin Hives Treatment Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Type
      • 8.3.3.2.2.By Treatment
      • 8.3.3.2.3.By Route of Administration
      • 8.3.3.2.4.By Distribution Channel

9.Middle East and Africa Skin Hives Treatment Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Type
  • 9.2.2.By Treatment
  • 9.2.3.By Route of Administration
  • 9.2.4.By Distribution Channel
  • 9.2.5.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Skin Hives Treatment Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Type
      • 9.3.1.2.2.By Treatment
      • 9.3.1.2.3.By Route of Administration
      • 9.3.1.2.4.By Distribution Channel
  • 9.3.2.Saudi Arabia Skin Hives Treatment Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Type
      • 9.3.2.2.2.By Treatment
      • 9.3.2.2.3.By Distribution Channel
  • 9.3.3.UAE Skin Hives Treatment Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Type
      • 9.3.3.2.2.By Treatment
      • 9.3.3.2.3.By Route of Administration
      • 9.3.3.2.4.By Distribution Channel

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Skin Hives Treatment Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1.Otsuka Holdings Co., Ltd
  • 14.1.1.1.Business Overview
  • 14.1.1.2.Company Snapshot
  • 14.1.1.3.Product Services
  • 14.1.1.4.Financials (In case of listed)
  • 14.1.1.5.Recent Developments
  • 14.1.1.6.SWOT Analysis
• 14.2.Taiho Pharmaceutical Co., Ltd.
• 14.3.Amneal Pharmaceuticals LLC
• 14.4.Galderma SA
• 14.5.F. Hoffmann-La Roche AG
• 14.6.Novartis AG
• 14.7.Dr. Reddy's Laboratories, Ltd.
• 14.8.Glenmark Pharmaceuticals Ltd.
• 14.9.Sanofi SA

15.Strategic Recommendations

16.About Us Disclaimer